WebThe Oncotype DX Breast Recurrence Score test provides valuable information you can use to personalize a treatment plan specifically for each patient’s tumor profile. OVERVIEW …

Targeted Cancer Therapy Rs Oncology

WebDec 11, 2024 · In prostate cancer, the Oncotype DX Genomic Prostate Score ® test predicts disease aggressiveness and further clarifies the current and future risk of the cancer prior to treatment intervention,... WebPurpose: Oncotype DX, a gene expression assay widely employed to aid decision making on adjuvant chemotherapy use in patients with primary oestrogen receptor-positive (ER+) … breats calcifications

Home Precision Oncology

WebJan 14, 2024 · Professor Sparano and co-investigators developed the new RSClin tool that integrates the RS with the patient’s age as well as tumour grade and size using a patient-specific meta-analysis that included data from 10,004 women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative and node-negative … WebDec 11, 2024 · The 21-gene recurrence score (RS) is one such tool already in use and helps determine whether patients who have estrogen-receptor positive, HER2 -negative, and node-negative breast cancer benefit from adjuvant chemotherapy. WebOnline Ordering Portal Signup By signing up, physicians and delegates can have access to the benefits of Exact Sciences' online ordering portal Secure and HIPAA compliant portal Place orders online any time Assign delegates to place your orders Obtain results as soon as they become available Retain all Oncotype DX results in one place breats bones